Health practitioners' perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic review.
Journal
Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
22
12
2020
received:
01
11
2020
accepted:
26
01
2021
pubmed:
4
2
2021
medline:
16
12
2021
entrez:
3
2
2021
Statut:
ppublish
Résumé
As interest in reproductive genetic carrier screening rises, with increased availability, the role of healthcare practitioners is central in guiding uptake aligned with a couples' values and beliefs. Therefore, practitioners' views on implementation are critical to the success of any reproductive genetic carrier screening programme. To explore healthcare practitioners' perceptions of the barriers and enablers to implementation. We undertook a systematic review of the literature searching seven databases using health practitioner, screening and implementation terms returning 490 articles. Screening led to the inclusion of 26 articles for full-text review. We found three interconnected themes relating to reproductive genetic carrier screening: (i) use and impact, (ii) practitioners' beliefs and expectations and (iii) resources. Barriers and enablers to implementation were present within each theme and grouping these determinants by (a) community for example lack of public interest, (b) practitioner for example lack of practitioner time and (c) organisation for example lack of effective metrics, reveals a preponderance of practitioner barriers and organisational enablers. Linking barriers with potential enablers leaves several barriers unresolved (e.g., costs for couples) implying additional interventions may be required. Future research should draw on the findings from this study to develop and test strategies to facilitate appropriate offering of reproductive genetic carrier screening by healthcare practitioners.
Sections du résumé
BACKGROUND
BACKGROUND
As interest in reproductive genetic carrier screening rises, with increased availability, the role of healthcare practitioners is central in guiding uptake aligned with a couples' values and beliefs. Therefore, practitioners' views on implementation are critical to the success of any reproductive genetic carrier screening programme.
AIM
OBJECTIVE
To explore healthcare practitioners' perceptions of the barriers and enablers to implementation.
MATERIALS & METHODS
METHODS
We undertook a systematic review of the literature searching seven databases using health practitioner, screening and implementation terms returning 490 articles.
RESULTS
RESULTS
Screening led to the inclusion of 26 articles for full-text review. We found three interconnected themes relating to reproductive genetic carrier screening: (i) use and impact, (ii) practitioners' beliefs and expectations and (iii) resources.
DISCUSSION
CONCLUSIONS
Barriers and enablers to implementation were present within each theme and grouping these determinants by (a) community for example lack of public interest, (b) practitioner for example lack of practitioner time and (c) organisation for example lack of effective metrics, reveals a preponderance of practitioner barriers and organisational enablers. Linking barriers with potential enablers leaves several barriers unresolved (e.g., costs for couples) implying additional interventions may be required.
CONCLUSION
CONCLUSIONS
Future research should draw on the findings from this study to develop and test strategies to facilitate appropriate offering of reproductive genetic carrier screening by healthcare practitioners.
Identifiants
pubmed: 33533079
doi: 10.1002/pd.5914
pmc: PMC8252081
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
708-719Subventions
Organisme : Australian Genomics Health Futures Mission
ID : Australian Genomics Health Futures Mission [GHFM73
Organisme : Australian Government's Medical Research Future Fund as part of the Australian Genomics Health Futures Mission [Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission) GHFM73390 (MRFF- G-MM)]
Informations de copyright
© 2021 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd.
Références
Genet Med. 2019 Sep;21(9):1948-1957
pubmed: 30760891
Eur J Hum Genet. 2008 Apr;16(4):435-44
pubmed: 18059419
J Community Genet. 2016 Apr;7(2):159-71
pubmed: 26842720
Community Genet. 2003;6(3):157-65
pubmed: 15237200
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Am J Med Genet A. 2013 Jan;161A(1):48-58
pubmed: 23239566
Int J Qual Health Care. 2014 Jun;26(3):321-9
pubmed: 24796491
Obstet Gynecol. 2005 Jun;105(6):1355-61
pubmed: 15932829
Prenat Diagn. 2014 Mar;34(3):246-50
pubmed: 24338659
Genet Med. 2018 Apr;20(5):513-523
pubmed: 29261177
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
BMC Med Ethics. 2017 Aug 1;18(1):46
pubmed: 28764782
J Eval Clin Pract. 2018 Feb;24(1):117-126
pubmed: 28371050
Qual Health Res. 2002 Nov;12(9):1284-99
pubmed: 12448672
BMC Health Serv Res. 2017 Feb 16;17(1):146
pubmed: 28209157
Genet Med. 2005 Sep;7(7):484-94
pubmed: 16170240
Public Health. 2003 Nov;117(6):396-403
pubmed: 14522154
Epigenet Insights. 2018 Dec 04;11:2516865718813122
pubmed: 30620008
Implement Sci. 2015 Aug 07;10:109
pubmed: 26249843
Twin Res Hum Genet. 2013 Apr;16(2):601-7
pubmed: 23331496
Eur J Hum Genet. 2019 May;27(5):691-700
pubmed: 30742054
Prenat Diagn. 2014 Feb;34(2):145-52
pubmed: 24222397
Prenat Diagn. 2020 Feb;40(3):301-310
pubmed: 31774570
Aust N Z J Obstet Gynaecol. 2020 Dec;60(6):976-979
pubmed: 32748403
J Community Genet. 2019 Apr;10(2):267-280
pubmed: 30259298
J Assist Reprod Genet. 2018 Sep;35(9):1631-1640
pubmed: 30069849
Br J Gen Pract. 2010 Nov;60(580):822-8
pubmed: 21062549
Genet Test. 2004 Winter;8(4):431-6
pubmed: 15684876
Genet Test Mol Biomarkers. 2011 Jul-Aug;15(7-8):517-23
pubmed: 21453058
J Med Genet. 2018 Nov;55(11):744-752
pubmed: 30068663
Genet Med. 2004 Sep-Oct;6(5):450-5
pubmed: 15371911
Fam Pract. 2006 Feb;23(1):106-10
pubmed: 16115832
J Cyst Fibros. 2014 Jan;13(1):99-105
pubmed: 23891279
J Genet Couns. 2016 Apr;25(2):395-404
pubmed: 26354338
Hum Reprod. 2013 Jun;28(6):1725-30
pubmed: 23589535
Fertil Steril. 2012 Feb;97(2):407-13
pubmed: 22137493
J Community Genet. 2016 Jul;7(3):203-14
pubmed: 27225888
Prenat Diagn. 2019 Apr;39(5):369-378
pubmed: 30756401
J Genet Couns. 2004 Feb;13(1):31-44
pubmed: 19739281
Obstet Gynecol. 2017 Mar;129(3):e35-e40
pubmed: 28225425
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
J Obstet Gynecol Neonatal Nurs. 2017 Jan - Feb;46(1):63-71
pubmed: 27875676
Aust N Z J Obstet Gynaecol. 2021 Apr;61(2):232-238
pubmed: 33135161